How was your experience with Vidarabine?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking Vidarabine?

What are you taking Vidarabine for?

Choose one
  • Other
  • Keratitis, Herpetic
  • Keratoconjunctivitis, Infectious

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did Vidarabine work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend Vidarabine to a friend?

Uses of Vidarabine


Vidarabine is used in the treatment of:

  • Keratitis, Herpetic
  • Keratoconjunctivitis, Infectious

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

Vidarabine Brand Names

Vidarabine may be found in some form under the following brand names:

Vidarabine Drug Class

Vidarabine is part of the drug class:

Vidarabine Interactions

This is not a complete list of Vidarabinedrug interactions. Ask your doctor or pharmacist for more information.

Vidarabine Dosage

Take vidarabine exactly as prescribed by your doctor. Follow the directions on your prescription label carefully.

The Vidarabine dose your doctor recommends will be based on the following (use any or all that apply):

  • the condition being treated
  • other medical conditions you have
  • other medications you are taking
  • how you respond to this medication
  • your weight
  • your height
  • your age
  • your gender

Vidarabine is available in the following doses:

  • Vidarabine Ophthalmic 3% Ophthalmic Ointment

Forms of Medication

Vidarabine is available in the following forms:

  • Injectable Solution

All RxWiki content including health news, medication pages, and condition pages published prior to February 2023, was written and maintained by on-staff pharmacists. Please be advised that this content is no longer actively maintained and may now contain outdated information. If you have any questions regarding previously published content, please contact